. home.aspx

NEWS

home.aspx
   


Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access

March 20, 2020 / BioSpace
SHARESHARESHARE

Adaptive Biotechnologies Corp. (Nasdaq: ADPT) and Microsoft Corp. (Nasdaq: MSFT) on Friday announced they will leverage their existing partnership mapping population-wide adaptive immune responses to diseases at scale to study COVID-19. Finding the relevant immune response signature may advance solutions to diagnose, treat and prevent the disease, augmenting existing research efforts that primarily focus on the biology of the virus. These data will be made freely available to any researcher, public health official or organization around the world via an open data access portal.